ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
3,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4,1,Migraine,Migraine headaches,Headaches,Nerv,N
4,2,Migraine with aura,Migraine headaches,Headaches,Nerv,N
5,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
6,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
7,1,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
8,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
8,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
10,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
10,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
11,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
11,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
12,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
13,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
13,2,Costochondritis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
13,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
14,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
14,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
15,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
17,1,Headache,Headaches NEC,Headaches,Nerv,N
18,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
19,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,2,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
20,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
20,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
21,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
22,1,Cerebellar haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
23,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
23,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
23,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
23,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
23,7,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
23,8,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
24,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
24,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
24,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
25,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
25,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
25,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
25,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
25,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
25,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
25,7,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
25,8,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
25,9,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
25,10,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
25,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
25,12,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
25,13,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
25,14,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
26,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
27,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
27,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
28,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,1,Headache,Headaches NEC,Headaches,Nerv,N
30,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
30,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
30,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
30,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
30,5,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
30,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
30,7,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
30,8,High density lipoprotein decreased,Cholesterol analyses,Lipid analyses,Inv,N
30,9,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
30,10,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
30,11,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
30,12,Red cell distribution width increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
30,13,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
30,14,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
31,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
31,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
31,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
31,4,Vitamin A increased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
32,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
32,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
32,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
32,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
32,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
32,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,8,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
34,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
35,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
35,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
36,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
37,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
38,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
38,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
38,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
38,4,Hypervitaminosis D,Hypervitaminoses NEC,Vitamin related disorders,Metab,N
38,5,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
38,6,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
38,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
39,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
40,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
40,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
41,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
41,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
42,1,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
43,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
44,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
45,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
46,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
46,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
47,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
47,2,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
49,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
